Renal function and impact on drug clearance

Overview

Renal impairment reduces clearance of renally-eliminated drugs and metabolites, requiring dose or interval adjustment guided by estimated glomerular filtration rate (eGFR) or creatinine clearance - unlike hepatic impairment, renal function has well-validated formula-based estimation tools enabling relatively precise, standardised dose-adjustment guidance for most affected drugs
Relevant to dosing consideration for any predominantly renally-cleared drug, particularly important given the high prevalence of chronic kidney disease and the frequency of acute kidney injury in hospitalised patients

eGFR-based dosing formulas assume relatively stable renal function and standard body habitus - these assumptions can break down in specific scenarios (rapidly changing acute kidney injury, extremes of muscle mass/body composition), meaning formula-derived eGFR should be interpreted with clinical judgement rather than applied mechanically in these atypical situations

Renal function should be reassessed at appropriate intervals during treatment with renally-cleared drugs, particularly in acutely unwell patients where function can change rapidly, rather than relying on a single baseline measurement throughout a prolonged treatment course
Drug and active/toxic metabolite clearance should both be considered - some drugs have renally-cleared active metabolites even when the parent drug itself is primarily hepatically cleared

Dose reduction or extended dosing interval for renally-cleared drugs, matched to the degree of renal impairment per validated dosing references
Drug avoidance or specific caution for nephrotoxic agents in patients with reduced renal function, given the risk of further renal injury compounding the dosing challenge

eGFR formula limitations in rapidly changing renal function or atypical body composition, renally-cleared active metabolites (e.g. morphine, see ), nephrotoxic drug avoidance in renal impairment, augmented renal clearance in specific critically ill populations
eGFR-based dosing formulas are validated for relatively stable renal function and typical body composition - in acute kidney injury (rapidly changing function) or atypical body habitus (very high/low muscle mass), a calculated eGFR may not accurately reflect true drug-clearing capacity at that moment, requiring clinical judgement and more frequent reassessment rather than a single formula-derived value applied throughout treatment

4 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.